MRKR – marker therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

MRKR

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/9

08:11 am

mrkr

Marker Therapeutics (NASDAQ:MRKR) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.

Medium Report

Marker Therapeutics (NASDAQ:MRKR) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.

Report

12/8

11:02 am

mrkr

Marker Therapeutics (NASDAQ:MRKR) had its "buy" rating reaffirmed by analysts at UBS Group AG.

Medium Report

Marker Therapeutics (NASDAQ:MRKR) had its "buy" rating reaffirmed by analysts at UBS Group AG.

Report

12/8

09:14 am

mrkr

Marker Therapeutics (NASDAQ:MRKR) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.

Medium Report

Marker Therapeutics (NASDAQ:MRKR) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.

Report

12/8

08:30 am

mrkr

Marker Therapeutics initiated with a Buy at H.C. Wainwright

Medium Report

Marker Therapeutics initiated with a Buy at H.C. Wainwright

Report

12/8

08:30 am

mrkr

Marker Therapeutics initiated with a Buy at H.C. Wainwright

Medium Report

Marker Therapeutics initiated with a Buy at H.C. Wainwright

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.